Pharmstandard International’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $7.72M | Hold |
750,632
| – | – | 26.59% | 2 |
|
|
2018
Q2 | $5.04M | Sell |
750,632
-231,638
| -24% | -$1.56M | 20.23% | 2 |
|
|
2018
Q1 | $8.44M | Hold |
982,270
| – | – | 21.2% | 3 |
|
|
2017
Q4 | $20.4K | Hold |
982,270
| – | – | 21.01% | 2 |
|
|
2017
Q3 | $17.4M | Hold |
982,270
| – | – | 50.6% | 1 |
|
|
2017
Q2 | $11.1M | Hold |
982,270
| – | – | 38.52% | 1 |
|
|
2017
Q1 | $12.6M | Sell |
982,270
-1,300
| -0.1% | -$16.7K | 33.57% | 2 |
|
|
2016
Q4 | $21.6M | Buy |
+983,570
| New | +$21.6M | 18.63% | 2 |
|